Thursday 30 May 2013

Pacira Pharmaceuticals, Inc. Announces Positive Interim Analysis of EXPAREL in Femoral Nerve Block f

Pacira Pharmaceuticals, Inc. Announces Positive Interim Analysis of EXPAREL ...DailyFinanceWe look forward to initiating the Phase 3 portion of this trial and ultimately to providing orthopedic patients with a new option that could significantly contribute to the management of their postsurgical pain by replacing a perineural catheter, drug ...http://www.dailyfinance.com/2013/05/29/pacira-pharmaceuticals-inc-announces-positive-inte/

No comments:

Post a Comment